Stockreport

Beta Bionics: Speculative Appeal After An Eventful Start To The Year [Seeking Alpha]

Beta Bionics, Inc.  (BBNX) 
PDF BBNX's 2026 revenue guidance of $130–$135 million signals minimal growth from Q4's annualized $128 million, raising concerns about sustained operational losses. Despi [Read more]